Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beena Kumar

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Oncotarget|April 19, 2017
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinomaRhiannon Coulson, Seng H Liew, Angela A Connelly, et al.
NPJ Precision Oncology|September 5, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBCNatasha K Brockwell, Jai Rautela, Katie L Owen, et al.
Oncogene|October 24, 2018
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancerTracy L Leong, Velimir Gayevskiy, Daniel P Steinfort, et al.
Science Translational Medicine|July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Oncotarget|April 19, 2017
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinomaRhiannon Coulson, Seng H Liew, Angela A Connelly, et al.
NPJ Precision Oncology|September 5, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBCNatasha K Brockwell, Jai Rautela, Katie L Owen, et al.
Oncogene|October 24, 2018
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancerTracy L Leong, Velimir Gayevskiy, Daniel P Steinfort, et al.
Science Translational Medicine|July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.
Pageof 8